Literature DB >> 8426397

How safe is 1% alum irrigation in controlling intractable vesical hemorrhage?

A K Goswami1, R K Mahajan, R Nath, S K Sharma.   

Abstract

A prospective study was done to evaluate the efficacy and safety of intravesical instillation of 1% alum solution in 12 cases of hematuria of vesical origin, uncontrolled by saline irrigation for 24 hours via a 3-way Foley catheter. There were 10 cases of transitional cell carcinoma and 2 of radiation cystitis. Complete response was noted in 6 patients and a partial response in 4. Local side effects included suprapubic pain and vesical tenesmus, which were controlled by antispasmodic and/or analgesic drugs. Transient low grade pyrexia (maximum up to 38.2C) was noted in 4 patients. Among the other various clinical and biochemical parameters, serum aluminum level and prothrombin time showed statistically highly significant changes. Serum aluminum increased from an average baseline value of 1.68 to 3.36 mumol./l. without clinical evidence of aluminum toxicity and with levels well below the recommended safe limit. Prothrombin time increased parallel with the increase in serum aluminum level to a maximum of 1 1/2 times the control. Prothrombin values, therefore, can be used clinically, since they are readily obtainable whereas serum aluminum levels are not. Vesical irrigation with 1% alum solution is a safe method to control hematuria of vesical origin in properly selected cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426397     DOI: 10.1016/s0022-5347(17)36051-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies.

Authors:  Bernadette M M Zwaans; Laura E Lamb; Sarah Bartolone; Heinz E Nicolai; Michael B Chancellor; Stangel-Wójcikiewicz Klaudia
Journal:  Int Urol Nephrol       Date:  2018-08-21       Impact factor: 2.370

2.  Challenges and Opportunities in Radiation-induced Hemorrhagic Cystitis.

Authors:  Bernadette M M Zwaans; Heinz G Nicolai; Michael B Chancellor; Laura E Lamb
Journal:  Rev Urol       Date:  2016

Review 3.  Management of radiation cystitis.

Authors:  Shaun G Smit; Chris F Heyns
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

4.  IN VITRO STUDY OF CONCENTRATION-EFFECT AND TIME-COURSE PATTERN OF WHITE ALUM ON ESCHERICHIA COLI O157:H7 GROWTH.

Authors:  Reza Shahriari; Saeed Salari; Saeed Shahriari
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

5.  Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation.

Authors:  Mary E Westerman; Stephen A Boorjian; Brian J Linder
Journal:  Int Braz J Urol       Date:  2016 Nov-Dec       Impact factor: 1.541

Review 6.  Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.

Authors:  Joanna Chorbińska; Wojciech Krajewski; Romuald Zdrojowy
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.